DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

By Davis H.L.   Millan C.L.B.   Mancini M.   McCluskie M.J.   Hadchouel M.   Comanita L.   Tiollais P.   Whalen R.G.   Michel M.-L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 849-852

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

By Zheng B.-J.   Ng M.-H.   He L.-F.   Yao X.   Chan K.-W.   Yuen K.-Y.   Wen Y.-M.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4219-4225

Elsevier

Access to resources Recommend Favorite

Liver Transplantation in HBsAg + Patients With Postoperative Immunoprophylaxis

By Langrehr J.M.   Guckelberger O.   Neumann U.   Berg T.   Schrem H.   Kratschmer B.   Knoop M.   Steinmuller T.   Lemmens H.P.   Keck H.   Bechstein W.O.   Neuhaus R.   Hopf U.   Neuhaus P.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2841-2842

Elsevier

Access to resources Recommend Favorite

False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines

By Otag F.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3734-3737

Elsevier

Access to resources Recommend Favorite

Optimization of a Therapeutic Vaccine Candidate by Studying Routes, Immunization Schedules and Antigen Doses in HBsAg-positive Transgenic Mice

By  

Euroasian Journal of Hepato-Gastroenterology, Vol. 4, Iss. 2, 2014-07 ,pp. : 70-78

Jaypee Infomedia

Access to resources Recommend Favorite